• Explore /
  • Poster
  • / Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised prostate cancer: The ANZUP ENZARAD Trial (ANZUP 1303).

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised prostate cancer: The ANZUP ENZARAD Trial (ANZUP 1303).

Abstract Poster

Authors

null

Scott G. Williams

Peter MacCallum Cancer Centre, East Melbourne, Australia

Scott G. Williams , Ian D. Davis , Christopher Sweeney , Martin R. Stockler , Andrew James Martin , Vittorio Marchesin , Olwyn Deignan , Ray McDermott , Anne Poh Long , Felicia T Roncolato , Sonia Yip , Wendy Hague , Emily Tu , Xanthi Coskinas , Paul Linh Nguyen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

ACTRN12614000126617

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS5078)

DOI

10.1200/jco.2015.33.15_suppl.tps5078

Abstract #

TPS5078

Poster Bd #

67b

Abstract Disclosures

Similar Posters

First Author: Scott Williams

First Author: Scott G. Williams

First Author: Scott Williams

First Author: Junlong Zhuang